Both in Pharmaceuticals
Edgewise Therapeutics vs Arcutis Biotherapeutics
Over the past year EWTX returned +109.2% and ARQT returned +34.6%; their daily moves had a correlation of 0.28.
EWTX +109.2% ARQT +34.6%Growth of $1, one year, split-adjusted
| Metric | EWTX | ARQT |
|---|---|---|
| Price | $37.60 | $33.32 |
| Market cap | $4.08B | $4.19B |
| Today | −0.21% | +4.11% |
| 1 month | −6.0% | +39.3% |
| 6 months | +1.6% | +37.8% |
| Year to date | +51.5% | +14.7% |
| 1 year | +109.2% | +34.6% |
| Revenue growth (YoY) | — | +59.3% |
| Gross margin | — | 91.6% |
| Net margin | — | 11.6% |
| P/E (TTM) | — | 146.8× |
| Price / sales | — | 9.0× |
| Net cash | $460.7M | $129.7M |
| Dividend yield | — | — |
| Volatility (60d) | 41.4% | 54.0% |
| Short % of float | 16.7% | 18.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).